MedPath

Virtual Parental Presence on Induction of Anesthesia vs Premedication With Midazolam

Not Applicable
Not yet recruiting
Conditions
Anxiety
Surgery
Interventions
Behavioral: Virtual Parental Presence on Induction of Anesthesia
Behavioral: Midazolam
Registration Number
NCT05834049
Lead Sponsor
Stanford University
Brief Summary

This multi-center, prospective, clinical trial targets recruiting children undergoing inhalational induction of anesthesia. The primary objective of this study is to assess the Modified Yale Preoperative Anxiety Scale during induction between children receiving oral midazolam 0.5 mg/kg (max 20 mg) versus virtual parental presence on induction of anesthesia. Patients will be randomized to one of two groups by block randomization.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
322
Inclusion Criteria
  • children from ages 4 years to 8 years old undergoing outpatient surgery
  • children identified as needing premedication
  • ASA physical status I, II or III
  • planned inhalational induction
  • children presenting from home prior to surgery (not an inpatient)
  • English speaking parents and child
Exclusion Criteria
  • children with developmental delay
  • children with psychological / emotional disorders
  • children with altered mental status
  • children in whom midazolam may be medically contraindicated per the discretion of the anesthesia care team
  • children with language barrier
  • children who are not accompanied by someone able to consent (ie legal guardian)
  • children who are inpatient prior to surgery
  • children with expected difficult intubation/airway
  • children presenting for emergency surgery
  • family history or personal history of malignant hyperthermia / risk of MH
  • consent not obtained or withdrawal of consent
  • children with past history of violent behaviors during induction of anesthesia
  • cancellation of surgery
  • patients with a diagnosis of COVID-19 or a patient under investigation for COVID-19, including patients being treated with airborne precautions in the operating room
  • receipt of any type of medical sedative prior to induction of anesthesia, including (but not limited to) ketamine, and/or dexmedetomidine.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Virtual Parental Presence on Induction of Anesthesia groupVirtual Parental Presence on Induction of AnesthesiaUse of Facetime with child and parents during induction
Midazolam GroupMidazolam0.5 mg/kg oral midazolam (max 20 mg) will be given preoperatively.
Primary Outcome Measures
NameTimeMethod
Change of Anxiety in childrenbaseline, immediately after the intervention

We will be using the modified Yale Preoperative Anxiety Scale (mYPAS) which was developed specifically to measure anxiety at anesthesia induction. It looks at activity, facial expression, alertness and arousal, vocalization and interaction with adults. It has a good validity against the State-Trait Anxiety Inventory for Children, as well as good intra and inter-observer reliability. mYPAS contains 5 items (activity, vocalisation, emotional expressivity, state of apparent arousal, and use of parent). The total score ranges from 0 to 22. Higher scores mean higher levels of anxiety.

Secondary Outcome Measures
NameTimeMethod
Induction complianceimmediately during anesthetic induction

The Induction Compliance Checklist (ICC) is a validated observational scale, used to describe the compliance of a child during induction of anesthesia. ICC contains 10 items. Score ranges from 0 to 1. 0 point indicates the behavior is not observed while 1 point means behavior is observed.

Change of parental anxietybaseline, immediately after anesthetic induction

The State-Trait Anxiety Inventory (STAI) is the gold standard for assessing anxiety in adults and has been used in over 1000 studies. It is comprises 20 questions. The total score ranges from 0-63. 0-9 indicates normal or no anxiety; 10-18 indicates mild to moderate anxiety; 19-29 indicates moderate to severe anxiety; and 30-63 indicates severe anxiety.

© Copyright 2025. All Rights Reserved by MedPath